Helen Graves

Helen Graves has a diverse work experience spanning multiple biotech and pharmaceutical companies. Helen is currently employed as a Principal Scientist at Alchemab Therapeutics Ltd since July 2021. Prior to this role, they served as a Senior Scientist at the same company from July 2020 to July 2021.

Before joining Alchemab Therapeutics, Helen worked at Camphos Therapeutics as a Senior Scientist from July 2018 to July 2020. In this role, they were responsible for establishing a new laboratory and successfully transferring existing assays from an academic lab to the biotech start-up. Helen also developed, optimized, and validated a suite of in vitro cell-based assays for screening small molecule libraries.

From July 2015 to May 2018, Helen held the position of Principal Scientist - Near Patient Testing Group at Novartis. Helen'sresponsibilities included optimizing whole blood immunoassays for use on the rapid point-of-care Niji diagnostic device, planning and implementing exploratory studies, and leading a small team while designing and analyzing complex experiments.

Prior to Novartis, Helen worked as the Flow Cytometry Manager at Guy's and St. Thomas' NHS Foundation Trust from June 2011 to July 2015. In this role, they designed and validated flow cytometry assays for quality control of therapeutic cell products produced in the Good Manufacturing Practice Facility. Helen also provided scientific and technical advice to researchers in various disease areas.

Helen's work experience also includes a role as a Senior Associate Scientist in the Biomarker Team of Internal Medicine at Pfizer from 2008 to 2011. During this time, they independently developed novel assays for biomarker solutions, screened candidate compounds in proof-of-pharmacology biomarker assays, and utilized in vitro, ex vivo, and in vivo samples.

In addition to the above, Helen has had scientific roles at Tenovus, Vernalis, and Abbot Diagnostics earlier in their career, where they gained experience in cancer immunotherapy, oncology research, and enzyme-linked antibody production for in-vitro diagnostic assays.

Helen Graves earned an MBiochem degree in Biochemistry from the University of Bath from 2004 to 2008. Prior to that, they studied at Maidstone Girls' Grammar School, with the specific degree and field of study information unknown.